Cure

NOVAGOLD Reports First Quarter 2024 Financial Results

Retrieved on: 
Wednesday, April 3, 2024
Iron Dog, Learning, ANCSA, Environmental protection, Salmon, Bank statement, Investment, Nature, SCAC, Water quality, K300, Hydrology, Science, Partnership, Alaska Natives, Education, EDGAR, Calista Corporation, TKC, Feasibility study, Social responsibility, Alaska Supreme Court, Supreme court, Safety, Federal, State, Weather, Judiciary of Alaska, Sport, Internet, Sleep, Human, University, Certification, TSX, Work, Cure, Mining, Health, Earthjustice, ADNR, Barrick Gold, Form 10-Q, Gold, Bethel Regional High School, Groundwater, Fishery, Music, Alaska Native corporation

VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company” (NYSE American, TSX: NG) today released its 2024 first quarter financial results and an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”).

Key Points: 
  • VANCOUVER, British Columbia, April 03, 2024 (GLOBE NEWSWIRE) -- NOVAGOLD RESOURCES INC. (“NOVAGOLD” or “the Company” (NYSE American, TSX: NG) today released its 2024 first quarter financial results and an update on its Tier One1 gold development project, Donlin Gold, which NOVAGOLD owns equally with Barrick Gold Corporation (“Barrick”).
  • Details of the financial results for the quarter ended February 29, 2024, are presented in the consolidated financial statements and quarterly report filed on Form 10-Q on April 3, 2024, that is available on the Company’s website at www.novagold.com, on SEDAR+ at www.sedarplus.ca, and on EDGAR at www.sec.gov.
  • During the first quarter of 2024, with the support from the owners and the Donlin Gold LLC Board, numerous important activities were conducted.
  • In the first quarter of 2024, Donlin Gold finalized another Shared Values Statement, bringing the total count to 16.

Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update

Retrieved on: 
Wednesday, March 27, 2024
Research, NCI, AON, Development, Sarcoma, Disease, Neuroblastoma, Shareholder, Patient, CNS, Fast Track, Cash, SBIR, NDA, Syndrome, Cancer, MRR, CLR, BNS, University, Head, External beam radiotherapy, Cure, Wisconsin Alumni Research Foundation, WAM, HERE, Completeness, Safety, Tat, Intellectual property, Patent, PLE, WARF, Symantec Endpoint Protection, Tranche, UW, Pharmaceutical industry

FLORHAM PARK, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced financial results for the year ended December 31, 2023, and provided a corporate update.

Key Points: 
  • FLORHAM PARK, N.J., March 27, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced financial results for the year ended December 31, 2023, and provided a corporate update.
  • Net cash used in operating activities during the twelve months ended December 31, 2023, was approximately $32.4 million.
  • General and Administrative Expense: G&A expense for the year ended December 31, 2023, was $10.7 million, compared to $9.6 million for the year ended December 31, 2022.
  • Cellectar management will host a conference call for investors today, March 14, 2024, beginning at 8:30 am Eastern Time to discuss these results and answer questions.

CURE OPENS XSEED AWARD APPLICATIONS TO SUPPORT UNDERFUNDED AND UNDERREPRESENTED NYC LIFE SCIENCE STARTUPS WITH UP TO $500,000

Retrieved on: 
Tuesday, April 9, 2024
Xchange, Pharmacology, Health, Mentorship, NYCEDC, Health equity, Research, Female, Doctor of Philosophy, Faculty, NIH, Male, Syneos Health, MPH, Pediatrics, Drug development, Economic development, Cure, Nursing

Deerfield Management, a New York City-based healthcare investment firm, founded and supports the XSeed Award.

Key Points: 
  • Deerfield Management, a New York City-based healthcare investment firm, founded and supports the XSeed Award.
  • The deadline for XSeed Award application submissions is May 31, 2024, and virtual finalist presentations will be June 28, 2024.
  • "Deerfield is pleased to continue our collaboration on the transformational XSeed program, alongside the NYCEDC, Cure and the experts who comprise our enthusiastic XSeed Award Leadership Committee."
  • "We look forward to welcoming the XSeed Award winners who, along with the Cure Xchange Challenge winners, are startups advancing health through collaboration and community building via Cure."

Safety Shot Taps Music and Film Industry Veteran Jordan Schur as New President and Company Board Member

Retrieved on: 
Wednesday, March 13, 2024
Shwayze, Suretone Records, Angel, ZZ Top, Growth, Lionsgate Films, Holmes & Watson, MCA Records, Black Angels, Safety, Sony Pictures, Partnership, Universal Music Group, Sonic Youth, Television, Flip Records, Intuition, Warrior, Airwave, Staind, Angels & Airwaves, Record, Rapture-Palooza, The Kid, Geffen Records, Limp Bizkit, MCA, Lionsgate, Creativity, Laurence, Africa Speaks!, Kid, Music, MSP, Live, New Found Glory, Root, Cure, Film industry

JUPITER, FL, March 13, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”), a pioneer in innovative well-being solutions, is excited to announce that American entrepreneur, record executive, and film producer Jordan Schur has been appointed as President of the Company. Schur will also join the Company’s Board of Directors.

Key Points: 
  • With tremendous success throughout a storied career in the music and film industries, Schur aims to significantly boost brand awareness for Safety Shot.
  • JUPITER, FL, March 13, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company” or “Safety Shot”), a pioneer in innovative well-being solutions, is excited to announce that American entrepreneur, record executive, and film producer Jordan Schur has been appointed as President of the Company.
  • “I am honored to join the Safety Shot team and to accelerate the next stage of growth for Safety Shot.
  • In 2006 Schur founded Los Angeles-based Suretone Entertainment, an independent full-service entertainment company that has consistently impacted culture in music, film, and television.

Philadelphia Phillies partner with the National Pediatric Cancer Foundation® for "Cut and Color Funds the Cure®"

Retrieved on: 
Saturday, March 23, 2024
Philadelphia Phillies, Research, Hospital, Cancer, Cure, Nursing

CLEARWATER, Fla., March 22, 2024 /PRNewswire/ -- The Philadelphia Phillies joined the National Pediatric Cancer Foundation (NPCF™) in the fight against childhood cancer at a "Cut and Color Funds the Cure" event at Bay Care ballpark.

Key Points: 
  • CLEARWATER, Fla., March 22, 2024 /PRNewswire/ -- The Philadelphia Phillies joined the National Pediatric Cancer Foundation (NPCF™) in the fight against childhood cancer at a "Cut and Color Funds the Cure" event at Bay Care ballpark.
  • The program's goal is to bring awareness and raise money for pediatric cancer research and continue to work toward a cure for the 43 children diagnosed with cancer every day.
  • "The support of the Philadelphia Phillies in our fight to end childhood cancer is invaluable," said National Pediatric Cancer Foundation CEO David Frazer.
  • The National Pediatric Cancer Foundation, a nonprofit organization headquartered in Tampa, is dedicated to funding research to eliminate childhood cancer.

TSC Alliance® to Host 23rd Annual Comedy for a Cure® on April 14 in Los Angeles

Retrieved on: 
Friday, March 15, 2024
TSC, Jim, Learning, Parks and Recreation, Disease, Patient, The King of Queens, Neoplasm, DSM-IV codes, Research, Courage, Vibiana, The Tonight Show, Ovation, Movement disorder, Jazz, Jazz Pharmaceuticals, Comedy, Cure, Pharmaceutical industry

LOS ANGELES, March 15, 2024 /PRNewswire/ -- Today, the TSC Alliance ® announced its 23nd Annual Comedy for a Cure ® will be held Sunday, April 14, at the historic Vibiana in Los Angeles.

Key Points: 
  • LOS ANGELES, March 15, 2024 /PRNewswire/ -- Today, the TSC Alliance ® announced its 23nd Annual Comedy for a Cure ® will be held Sunday, April 14, at the historic Vibiana in Los Angeles.
  • "Every year, Comedy for Cure helps our organization raise significant funds to further TSC research, offer expanded support programs and increase awareness about the disease," said Kari Luther Rosbeck, TSC Alliance President & CEO.
  • "Over the years, this signature event has raised almost $6 million cumulatively to help improve the lives of everyone affected by TSC."
  • Comedy for a Cure also offers the opportunity to pay tribute to those who have made significant impacts in the right against TSC.

Aegis Living Appoints Renowned Pulmonary and Sleep Expert Dr. Raj Dasgupta as Chief Medical Officer

Retrieved on: 
Tuesday, March 12, 2024
Internal medicine, Health, Longevity, Thomas Jefferson University, Sleep hygiene, Associate, Philosophy, Aegis, Diabetes, Television, Medicine, FACP, Research, Sleep, CNN, Columbia University, University, USC, Quality of life, Jefferson Abington Hospital, News, Michigan State University, Cognitive behavioral therapy, Mount Sinai West, FCCP, Nursing care plan, CMO, Cure, ABC News, Dementia

BELLEVUE, Wash., March 12, 2024 /PRNewswire/ -- Aegis Living, a national leader in senior assisted living and memory care, has appointed Raj "Dr. Raj" Dasgupta MD, FACP, FCCP, FAASM, as Chief Medical Officer (CMO). Dr. Raj's appointment strengthens Aegis' healthcare expertise to further integrate wellness and longevity into the care of its residents, families and team members.

Key Points: 
  • BELLEVUE, Wash., March 12, 2024 /PRNewswire/ -- Aegis Living , a national leader in senior assisted living and memory care, has appointed Raj "Dr. Raj" Dasgupta MD, FACP, FCCP, FAASM, as Chief Medical Officer (CMO).
  • While one's lifespan defines how long they will live, healthspan is the quality of life that Aegis Living aims to impact.
  • While the primary beneficiaries will be Aegis Living residents and families, Aegis also aims to support and influence team members.
  • "I am honored to join the leadership team at Aegis Living to advance the level of care and wellness not yet experienced in senior living," said Dr. Raj.

Dr. Samuel Lin Continues Partnership With Haute Beauty Network

Retrieved on: 
Friday, February 2, 2024
Partnership, Northwestern University, Certification, AAPS, ABMS, Plastic surgery, Knowledge, Science, Bachelor, Feinberg School of Medicine, Rhinoplasty, Division, Medical specialty, Internet celebrity, Expert, Plastic and Reconstructive Surgery, Biomedicine, Mentorship, Literature, MD Anderson Cancer Center, Elective surgery, Honors colleges and programs, Medical education, Harvard University, Harvard Medical School, Physician, Northwestern Memorial Hospital, Breast surgery, Biomedical engineering, Cure, Pearl, Editorial, Associate, University, Student, Editor-in-chief, Dentistry

NEW YORK, Feb. 2, 2024 /PRNewswire-PRWeb/ -- Dr. Samuel Lin is a double board certified Plastic Surgeon and Associate Professor of Surgery at Harvard Medical School who practices in Boston, Massachusetts. Dr. Lin received his Bachelor's degree in Biomedical Engineering at Northwestern University and was enrolled in the Honors Program for Medical Education at Northwestern University, Feinberg School of Medicine, Chicago, Illinois. He then completed a five-year-residency in Otolaryngology-Head and Neck Surgery followed by a three-year-residency in Plastic and Reconstructive Surgery at Northwestern Memorial Hospital. This was followed by a one-year fellowship appointment in Microvascular Reconstructive Surgery at the world-renowned University of Texas M.D. Anderson Cancer Center in Houston, Texas. Throughout the course of his training, Dr. Lin gained state-of-the-art skills in a multitude of reconstructive and cosmetic procedures with his background in Head and Neck Surgery providing him with additional expertise in Plastic and Reconstructive Surgery. He has also been named a Top Influencer in #PlasticSurgery.

Key Points: 
  • Nose Expert from Boston, Dr. Samuel Lin, continues his partnership with Haute Beauty Network, now in his sixth year.
  • NEW YORK, Feb. 2, 2024 /PRNewswire-PRWeb/ -- Dr. Samuel Lin is a double board certified Plastic Surgeon and Associate Professor of Surgery at Harvard Medical School who practices in Boston, Massachusetts.
  • Dr. Lin is board certified by both the American Board of Plastic Surgery and the American Board of Otolaryngology-Head and Neck Surgery.
  • Dr. Lin, his team, and his collaborators regularly publish scientific papers in the literature to further knowledge about plastic surgery and other topics.

New Arkansas Organization Will Support Healthy Families by Listening to Parents, Advocating for Better Maternal Health Care

Retrieved on: 
Wednesday, January 17, 2024
Mortality, AIM, Death, Woman, Medicine, Statistics, Legislation, Research, Hospital, Heifer International, Medicaid, Mother, PTSD, Life, Maternal health, Multimedia, Insurance, NICU, University, Mental health, Anxiety, Nursing, Pregnancy, Cure, Disease, Mental, Prenatal care, Workforce, Parent, Infant, Birth control

LITTLE ROCK, Ark. , Jan. 17, 2024 /PRNewswire/ -- A new maternal health non-profit organization has launched a digital platform for Arkansas parents to share their personal experiences before, during and after pregnancy. Maternal healthcare includes prenatal care, safe delivery and postpartum support like mental healthcare.

Key Points: 
  • Arkansans for Improving Maternal Health promotes healthy moms, which leads to healthier families and stronger communities
    LITTLE ROCK, Ark.
  • , Jan. 17, 2024 /PRNewswire/ -- A new maternal health non-profit organization has launched a digital platform for Arkansas parents to share their personal experiences before, during and after pregnancy.
  • Driven by research that shows Arkansas has the highest maternal mortality rate in the nation and that healthy moms lead to healthier families and stronger communities, Arkansans for Improving Maternal Health (AIM) is gathering stories from families impacted by poor maternal health outcomes.
  • Research by the Arkansas Maternal Mortality Review Committee shows that 92% of maternal deaths in Arkansas could be prevented by enhancing the quality of maternal health care.

Music can ease the January blues – but the types of songs that work depend on your age and mindset

Retrieved on: 
Tuesday, January 16, 2024
Noise, Patient, Trauma, Research, Weight loss, Sadness, Happiness, Mental health, Anxiety, Cure, Emotion, Exercise, Sensation, Pleasure, Catharsis, Music

So what type of music should you turn to in order to boost your mood?

Key Points: 
  • So what type of music should you turn to in order to boost your mood?
  • But, as illogical as it may seem, that sensation of sadness may actually help lead to positive emotions.
  • For example, our preference for classical music increases as we age while our preference for rock decreases.
  • But further findings have shown that a listener’s age can also affect the types of music that improve their low mood.